Skip to search formSkip to main contentSkip to account menu

ulifloxacin

Known as: 1H,4H-(1,3)thiazeto(3,2-a)quinoline-3-carboxylic acid, 6-fluoro-1-methyl-4-oxo-7-(1-piperazinyl)-, 6-fluoro-1-methyl-4-oxo-7-(1-piperazinyl)-1H,4H-[1,3]Thiazeto[3,2-a]quinoline-3-carboxylic acid, 6-fluoro-1-methyl-7-(1-piperazinyl)-4-oxo-4H-(1,3)thiazeto(3,2-a)quinoline-3-carboxylic acid 
National Institutes of Health

Related topics

Related topics

5 relations

Broader (4)

Anti-Bacterial AgentsFluoroquinolonesPiperazinesTopoisomerase II Inhibitors

Narrower (1)

NM-394

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Stability study of Prulifloxacin and Ulifloxacin in human plasma by HPLC–DAD
Abstract A new and specific HPLC–DAD method for the direct determination of Prulifloxacin and its active metabolite, Ulifloxacin… 
2011
2011
Antipneumococcal Activity of Ulifloxacin Compared to Levofloxacin and Ciprofloxacin
Streptococcus pneumoniae (pneumococcus) is a leading cause of morbidity and mortality worldwide, being responsible for over a… 
2008
2008
Simultaneous determination of Ciprofloxacin and the active metabolite of Prulifloxacin in aqueous human humor by high-performance liquid chromatography.
2008
2008
Proposal of membrane transport mechanism of protein-unbound ulifloxacin into epithelial lining fluid determined by improved microdialysis.
Microdialysis method (MD) is useful for sampling protein-unbound substances in vivo. Generally in the MD, a reference compound is… 
2008
2008
Antimicrobial Activity of Prulifloxacin Tested against a Worldwide Collection of Gastroenteritis-Producing Pathogens, Including Those Causing Traveler's Diarrhea
ABSTRACT Prulifloxacin, the prodrug of ulifloxacin (active component), is a newer fluoroquinolone with broad activity against… 
2007
2007
Determination of Ulifloxacin by Terbium-sensitized Fluorescence with Second-order Scattering and Its Applications
This paper reports the determination of ulifloxacin (UFX) by terbium-sensitized fluorescence using a second-order scattering… 
Review
2006
Review
2006
Pharmacologic characteristics of prulifloxacin.
2006
2006
Determination of the active metabolite of prulifloxacin in human plasma by liquid chromatography-tandem mass spectrometry.
Review
2006
Review
2006
Prulifloxacin: a new fluoroquinolone for the treatment of acute exacerbation of chronic bronchitis.
2005
2005
Interpretive Criteria for Disk Diffusion Susceptibility Testing of Ulifloxacin, the Active Metabolite of Prulifloxacin
Abstract Prulifloxacin, a new fluoroquinolone, is a prodrug whose active compound, ulifloxacin, is derived from its… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)